KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) EBT (2016 - 2025)

Historic EBT for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $714.0 million.

  • AbbVie's EBT fell 6573.9% to $714.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 7693.48%. This contributed to the annual value of $3.7 billion for FY2024, which is 4054.4% down from last year.
  • AbbVie's EBT amounted to $714.0 million in Q3 2025, which was down 6573.9% from $1.6 billion recorded in Q2 2025.
  • In the past 5 years, AbbVie's EBT registered a high of $4.9 billion during Q1 2022, and its lowest value of -$2.3 billion during Q4 2024.
  • Moreover, its 5-year median value for EBT was $2.0 billion (2023), whereas its average is $2.1 billion.
  • Per our database at Business Quant, AbbVie's EBT surged by 38341.07% in 2021 and then plummeted by 28721.12% in 2024.
  • Over the past 5 years, AbbVie's EBT (Quarter) stood at $4.3 billion in 2021, then plummeted by 30.58% to $3.0 billion in 2022, then tumbled by 59.12% to $1.2 billion in 2023, then plummeted by 287.21% to -$2.3 billion in 2024, then skyrocketed by 131.47% to $714.0 million in 2025.
  • Its EBT stands at $714.0 million for Q3 2025, versus $1.6 billion for Q2 2025 and $1.7 billion for Q1 2025.